Neoadjuvant immune-checkpoint inhibition is a promising emerging treatment approach for
patients with surgically resectable macroscopic stage III melanoma. The neoadjuvant setting …

Uveal melanoma represents a rare and aggressive subtype of melanoma with limited
treatment options and poor prognosis, especially in the metastatic setting. Tebentafusp, a …

Simple Summary The conceptualization of a “hot” tumor microenvironment has been
characterized by mainly T cell infiltration, whereas,“cold” or “immune-deserted” tumors were …

Background: Most patients with high-risk melanomas develop metastasis within the first few
years after diagnosis. However, late recurrence of melanoma is seen in patients that …

Background Choosing the adequate systemic treatment for melanoma is driven by clinical
parameters and personal preferences. Objective Evaluation of the impact of disease and …

Many patient-reported outcome measures (PROMs) have been used to study quality of life
(QOL) in the skin cancer population. Advanced melanoma and non-melanoma skin cancer …

Background Visits to an outpatient cancer clinic represent a challenging situation for
patients, which can trigger anxiety and helplessness in those affected. It is important to …

Figure 1 Lipodystrophy of the cheeks and enophthalmos twelve weeks following twelve
months of adjuvant therapy with nivolumab. our patient with immune-mediated localized …

Onkologische Systemtherapie bis zum bitteren Ende? Page 1 Editorial 1259 © 2021 The
Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & …

Metastatic pigmented epithelioid melanocytoma in a 7-year-old female Metastatic pigmented
epithelioid melanocytoma in a 7-year-old female J Dtsch Dermatol Ges. 2021 …